| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |